Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Mebendazole bulk supplier for pharma manufacturers

Mebendazole 100 mg Suppliers & Bulk Manufacturers

Available Forms: Chewable Tablets

Available Strengths: 100 mg

Reference Brands: Emverm (USA),

Category: Anthelmintic

Mebendazole is an anthelmintic (an-thel-MIN-tik) or anti-worm medication. It prevents newly hatched insect larvae (worms) from growing or multiplying in your body. Mebendazole is used to treat infections caused by worms such as whipworm, pinworm, roundworm, and hookworm.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

-

Mebendazole — third party manufacturing & bulk supply

Mebendazole 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Mebendazole listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Mebendazole →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Mebendazole is used for treating a range of intestinal worm infections, including pinworm, roundworm, hookworm, and whipworm. It works by blocking the worms’ ability to absorb glucose, which leads to their slow death and removal from the body.

Mebendazole is made from the active ingredient mebendazole, a synthetic benzimidazole derivative with broad-spectrum anthelmintic activity.

Common trade names include Vermox and Emverm.

Vermox was originally developed by Janssen Pharmaceuticals. Emverm is manufactured by Impax Laboratories (Amneal Pharmaceuticals). Several global and Indian manufacturers also produce generic mebendazole.

The generic name is mebendazole.

Brand names include Vermox and Emverm.

Mebendazole is manufactured in multiple countries including India, China, the United States (Emverm), and various European regions that produce both branded and generic formulations.

Related Products

Chloroquine Phosphate

Strength:
100 mg , 150 mg , 200 mg , 250 mg , 40 mg/ml

Form: Tablets / injection

Reference Brands: Aralen (USA), Nivaquine (EU), Lariago (India)

View Details
Triclabendazole

Strength:
250 mg

Form: Tablets

Reference Brands: Egaten (USA/EU), Fasigyl (EU)

View Details
Mefloquine Hydrochloride

Strength:
250 mg

Form: Tablets

Reference Brands: Lariam (USA/EU)

View Details
Diethylcarbamazine (Dec) Tablet

Strength:
100 mg

Form: Tablets

Reference Brands: Generic formulations available in various generic brands

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.